Why the study?
Accurate survival prediction guides clinical decisions, motivating the development of a machine learning model to predict one-year mortality in older patients with CAD and IGT or DM.
Population
451 older patients with CAD combined with IGT or DM
Design
Prospective cohort study
Follow-up
One-year
Authors
Loading...
High one-year mortality in this statin cohort warrants clinical caution; leaves open questions on comparative effectiveness requiring prospective trials.
A gradient boosting machine model accurately predicts one-year mortality in older Chinese patients with CAD and impaired glucose tolerance or diabetes, identifying NT-proBNP, albumin, and statin use as key prognostic factors.
Li et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: